BFS
UTHR icon

Bare Financial Services’s United Therapeutics UTHR Stock Holding History

Bare Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
28
+7
+33% +$3.94K ﹤0.01% 402
2026
Q1 		$12.5K Buy
21
+6
+40% +$2.99K ﹤0.01% 250
2025
Q4 		$7.31K Buy
15
+2
+15% +$931 ﹤0.01% 373
2025
Q3 		$5.45K Buy
13
+1
+8% +$336 ﹤0.01% 506
2025
Q2 		$3.45K Buy
12
+7
+140% +$2.09K ﹤0.01% 636
2025
Q1 		$1.54K Buy
+5
New +$1.71K ﹤0.01% 368

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bare Financial Services's UTHR Position: Q2 2026 in Review

Bare Financial Services increased its United Therapeutics (UTHR) stake by 33% in Q2 2026, buying an estimated $3.94K and bringing the position to 28 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Bare Financial Services first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bare Financial Services held 28 shares of United Therapeutics worth $15.2K as of Q2 2026.
  • Bare Financial Services bought 7 United Therapeutics shares in Q2 2026, an estimated $3.94K.
  • United Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #402 holding.
  • Bare Financial Services first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.